Swinson Benjamin, Waters Peadar S, Webber Laurence, Nathanson Les, Cavallucci David J, O'Rourke Nicholas, Bryant Richard D
Department of Surgery, Royal Brisbane and Women's Hospital, Herston, QLD, 4029, Australia.
Department of Surgery, Wesley Hospital, Auchenflower, QLD, 4066, Australia.
Surg Endosc. 2022 May;36(5):3332-3339. doi: 10.1007/s00464-021-08649-x. Epub 2021 Jul 30.
Minimally invasive splenectomy is now well established for a wide range of pathologies. Portal vein thrombosis (PVT) is increasingly being recognised as a complication of splenectomy. The aim was to determine the incidence and risk factors for PVT after laparoscopic splenectomy.
All cases of elective laparoscopic splenectomy performed from 1993 to 2020 were reviewed. Parameters recorded included demographics, diagnostic criterion and post-operative outcomes. Data were analysed using Minitab V18 with a p < 0.05 considered significant.
210 patients (103 female, 107 male) underwent laparoscopic splenectomy (14 to 85 years). A major proportion of cases were performed for ITP (n = 77, p = 0.012) followed by lymphoma (n = 28), indeterminate lesions (n = 21) and myelofibrosis (n = 19). Ten patients developed symptomatic portal vein thrombosis (4.8%). Patients presented most commonly with pain and fever and diagnosis was confirmed by computed tomography (CT) or ultrasonography (USS). There were 10 conversions (4.8%) to open and two postoperative deaths, one from PVT and one from pneumonia. The remaining nine patients were successfully treated with anticoagulation. Of 19 patients with myelofibrosis, six patients developed PVT (p = 0.0002). Patients who developed PVT had significantly greater specimen weights (1773 g vs 348 g, p < 0.001). Forty-three patients had a specimen weight of 1 kg or greater, and of these 9 developed portal vein thrombosis (21%), versus one with PVT of 155 with a specimen weight of less than 1 kg (p < 0.0001). Myelofibrosis (p = 0.0039), specimen weight (p < 0.001) and mean platelet count (p = 0.0049) were predictive of PVT.
A high index of suspicion for this complication should be maintained and prompt treatment with anticoagulation. High-risk patients should be considered for prophylactic anticoagulation and routine imaging of the portal vein.
微创脾切除术目前已广泛应用于多种病症。门静脉血栓形成(PVT)越来越被认为是脾切除术的一种并发症。本研究旨在确定腹腔镜脾切除术后PVT的发生率及危险因素。
回顾了1993年至2020年期间所有择期腹腔镜脾切除术病例。记录的参数包括人口统计学资料、诊断标准及术后结果。使用Minitab V18软件进行数据分析,p < 0.05被认为具有统计学意义。
210例患者(103例女性,107例男性)接受了腹腔镜脾切除术(年龄14至85岁)。大部分病例是因免疫性血小板减少性紫癜(ITP)进行手术(n = 77,p = 0.012),其次是淋巴瘤(n = 28)、性质不明的病变(n = 21)和骨髓纤维化(n = 19)。10例患者发生有症状的门静脉血栓形成(4.8%)。患者最常见的表现是疼痛和发热,通过计算机断层扫描(CT)或超声检查(USS)确诊。有10例(4.8%)转为开腹手术,2例术后死亡,1例死于PVT,1例死于肺炎。其余9例患者通过抗凝治疗成功治愈。19例骨髓纤维化患者中,6例发生PVT(p = 0.0002)。发生PVT的患者标本重量明显更大(1773 g对348 g,p < 0.001)。43例患者标本重量为1 kg或更大,其中9例发生门静脉血栓形成(21%),而标本重量小于1 kg的155例患者中有1例发生PVT(p < 0.0001)。骨髓纤维化(p = 0.0039)、标本重量(p < 0.001)和平均血小板计数(p = 0.0049)是PVT的预测因素。
应高度怀疑该并发症并及时进行抗凝治疗。对于高危患者应考虑预防性抗凝及门静脉的常规影像学检查。